Briquilimab

Briquilimab

Near Add Your Location

Accepting patients

JSP191-Based Conditioning

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
Learn more
  • Allogeneic Stem Cell Transplant
  • Monoclonal Antibody
  • Phase 2

Accepting patients

JSP191 (Briquilimab)

A Phase 1 Open-label, Dose-escalation, Safety, and Tolerability Study of JSP191 as a Second-line Therapy in Subjects With Lower-Risk Myelodysplastic Syndrome (LR-MDS)
Learn more
  • Monoclonal Antibody
  • Phase 1